Product Description
for the Treatment of Hypogonadal Men (Sourced from: https://clinicaltrials.gov/ct2/show/NCT02082197)
Mechanisms of Action: Unknown
Novel Mechanism: No
Modality: Unknown
Route of Administration: N/A
FDA Designation: *
Approval Status: Not Approved
Approved Countries: None
Approved Indications: None
Company: AbbVie
Company Location: Eastern America
Company Founding Year: 2013
Additional Commercial Interests: None
Clinical Description
Countries in Clinic:
Active Clinical Trial Count:
Recent & Upcoming Milestones
Highest Development Phases
Phase 3: Hypogonadism
Trial ID |
Trial |
Phase |
Trial Status |
Disease |
Primary Completion Date |
Probability of Success |
Latest Trial Update Date |
Data Updated |
|---|---|---|---|---|---|---|---|---|
NCT02082197 |
M13-886 | P3 |
Withdrawn |
Hypogonadism |
2015-06-01 |
2019-03-20 |
Treatments |
Recent News Events
Date |
Type |
Title |
|---|